ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Growth Shares
2 ASX growth shares I buy whenever they go on sale (like now)
Broker Notes
The Resmed share price collapse is a buying opportunity according to this broker
Healthcare Shares
Why will all eyes be on ResMed shares later this month?
Investing Strategies
Here's why I'm buying ASX shares right now for a 2024 stock market rally
Broker Notes
Morgans names the best ASX 200 shares to buy in October
Share Market News
Here are the top 10 ASX 200 shares today
Share Market News
3 high-quality ASX 200 blue chip shares to buy this month
Broker Notes
Top brokers name 3 ASX shares to buy next week
Best Shares
Top ASX shares to buy in October 2023
Share Fallers
Why Liontown, ResMed, Santos, and Zip shares are falling today
Share Market News
Here are the top 10 ASX 200 shares today
Share Gainers
Why ANZ, Lake Resources, ResMed, and Santos shares storming higher today
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
